MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

• Main Authors: E. Krasniqi (Author), A. Sacconi (Author), D. Marinelli (Author), L. Pizzuti (Author), M. Mazzotta (Author), D. Sergi (Author), E. Capomolla (Author), S. Donzelli (Author), M. Carosi (Author), A. Bagnato (Author), T. Gamucci (Author), S. Tomao (Author), C. Natoli (Author), P. Marchetti (Author), A. Grassadonia (Author), N. Tinari (Author), M. De Tursi (Author), E. Vizza (Author), G. Ciliberto (Author), L. Landi (Author), F. Cappuzzo (Author), M. Barba (Author), G. Blandino (Author), P. Vici (Author)
• Format: Book
• Published: BMC, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background In Western countries, ovarian cancer (OC) still represents the leading cause of gynecological cancer-related deaths, despite the remarkable gains in therapeutical options. Novel biomarkers of early diagnosis, prognosis definition and prediction of treatment outcomes are of pivota...